Skip to the page

Data / Form D filings / Mercury Bio, Inc.

Mercury Bio, Inc.: Form D filings

Mercury Bio, Inc., a biotechnology company in Santa Fe, NM, filed 5 Form D notices with the SEC between 2022 and 2025. The latest, on October 24, 2025, reports $2.4 million sold of a $8 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3900 PASEO DEL SOL, Santa Fe, NM, 87507
Phone
(505) 670-8490
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1952927

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 24, 2025New notice$7,954,094$2,376,107$5,577,9876Sep 30, 2025sec.gov
Feb 21, 2025New notice$2,541$2,5411Feb 13, 2025sec.gov
Apr 3, 2024New notice$2,000,000$149,987$1,850,0132Mar 7, 2024sec.gov
Feb 17, 2023New notice$3,054,071$1,154,071$1,900,0008Feb 3, 2023sec.gov
Nov 14, 2022New notice$200,000$200,0002Oct 15, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alex KoglinDirector
John TomesDirector
Mike RiceDirector
Paul LaurExecutive Officer, Director
Steve KiziukDirector
Dana BarnardDirector
Bruce McCormickExecutive Officer, Director
Kevin McDonaldDirector

Every Form D from the week of Oct 20, 2025 · All recent filings in New Mexico · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Mercury Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.